• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

BTB06584

CAS No. 219793-45-0

BTB06584 ( BTB )

产品货号. M13505 CAS No. 219793-45-0

BTB06584 is a novel acetohydroxyacid synthase(AHAS) inhibitor, a promising drug target against Mycobacterium tuberculosis (MTB).

纯度: >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥243 有现货
5MG ¥389 有现货
10MG ¥543 有现货
25MG ¥713 有现货
50MG ¥1013 有现货
100MG ¥1823 有现货
200MG ¥2819 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    BTB06584
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    BTB06584 is a novel acetohydroxyacid synthase(AHAS) inhibitor, a promising drug target against Mycobacterium tuberculosis (MTB).
  • 产品描述
    BTB06584 is a novel acetohydroxyacid synthase(AHAS) inhibitor, a promising drug target against Mycobacterium tuberculosis (MTB). BTB06584 is an IF1-dependent, selective inhibitor of the mitochondrial F1 Fo-ATPase.
  • 同义词
    BTB
  • 通路
    Endocrinology/Hormones
  • 靶点
    ATPase
  • 受体
    ATPase; Acetohydroxyacid synthase
  • 研究领域
    Metabolic Disease
  • 适应症
    ——

化学信息

  • CAS Number
    219793-45-0
  • 分子量
    417.82
  • 分子式
    C19H12ClNO6S
  • 纯度
    >98%(HPLC)
  • 溶解度
    DMSO: 84 mg/mL (201.04 mM)
  • SMILES
    O=S(C1=CC(OC(C2=CC=C(Cl)C=C2)=O)=C([N+]([O-])=O)C=C1)(C3=CC=CC=C3)=O
  • 化学全称
    2-nitro-5-(phenylsulfonyl)phenyl 4-chlorobenzoate

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Wang D, et al. J Chem Inf Model. 2013 Feb 25;53(2):343-53.
产品手册
关联产品
  • Bacoside A3

    Bacoside A3 is one of the components of Bacopa monnieri (L.) Wettst. bacoside A with antioxidant potential. Bacoside A3 shows comparatively higher neuroprotective response analysed as higher cell viability and decreased intracellular ROS.

  • Lycorine

    Lycorine inhibitsprotein synthesis and may inhibitascorbic acidbiosynthesis, although studies on the latter are controversial and inconclusive.

  • KM 91104

    KM 91104 is a cell permeable inhibitor of V-ATPase. KM91104 specifically targets the interaction between V-ATPase subunit A3 and subunit B2.